Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Scientists have found that a mutation tied to Alzheimer’s disrupts the production and quality of exosomes—tiny cell-made ...

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing ...

With aging, the intestine gradually loses its ability to regenerate after damage. An international research team involving ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial ...

Well-loved by skincare experts and a loyal legion of celebrity fans, including Meghan Markle, the cult classic cream is now ...

A glimmer of hope in the fight against cancer is emerging from laboratories, where research teams are studying an original ...

Blocking a single protein revs up T cells, boosting their energy reserves and helping them fight tumors longer in new mouse ...

Researchers have identified a stress-activated control mechanism that helps breast cancer cells reshape gene activity to survive and grow. Cells often encounter environmental pressures that can harm ...

ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to ...